Kenneth I Berger

6PUBLICATIONS
0CO-AUTHORS
Rehabilitation engineeringPacific Peoples theory of change models for healthPacific Peoples life courseAcoustics and noise control (excl. architectural acoustics)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 13, 2025
Efficacy of Switching Therapy From Alglucosidase Alfa to Avalglucosidase Alfa on Respiratory Function in Participants With Late-Onset Pompe Disease: A Post Hoc Analysis From the COMET Trial.

Priya S Kishnani, Matthias Boentert, Stephan Wenninger

|Jul 31, 2025
Correction: Changes in forced vital capacity over ≤ 13 years among patients with late-onset Pompe disease treated with alglucosidase alfa: new modeling of real-world data from the Pompe Registry.

Kenneth I Berger, Yin-Hsiu Chien, Alberto Dubrovsky

|Jun 19, 2024
Changes in forced vital capacity over ≤ 13 years among patients with late-onset Pompe disease treated with alglucosidase alfa: new modeling of real-world data from the Pompe Registry.

Kenneth I Berger, Yin-Hsiu Chien, Alberto Dubrovsky

|Aug 07, 2020
Airway Disease Presenting as Restrictive Impairment.

Albert Miller, Roberta M Goldring, Kenneth I Berger

|Jun 13, 2019
Forced vital capacity and cross-domain late-onset Pompe disease outcomes: an individual patient-level data meta-analysis.

Kenneth I Berger, Steve Kanters, Jeroen P Jansen

|Feb 21, 2018
Small Airway Disease Syndromes. Piercing the Quiet Zone.

Kenneth I Berger

Pageof 1

Frequent Collaborators